3-Bromopyruvate (3-BP) is a glycolytic inhibitor and a potential calorie restriction mimic that shows a variety of beneficial effects in several aging model systems. A chronic low dose of 3-BP was given to male Wistar rats for 4 weeks. The effect of 3-BP on age-dependent alteration on the activities of various transporters/exchangers and redox biomarkers (protein carbonyl [PC], sialic acid [SA], sulfhydryl group [–SH], intracellular calcium ion [Ca 2+ ]i, and osmotic fragility) was studied. In aged rats, 3-BP treatment increases the membrane-bound activities of Na + /K + -ATPase (NKA) and Ca 2+ -ATPase (PMCA), along with levels of –SH and SA. It also exerts a concomitant decrease in Na + /H + exchanger (NHE) activity and the levels of [Ca 2+ ]i, PC, and osmotic fragility in aged groups. 3-BP can be considered as a potential antiaging agent that induces a hormetic effect leading to amelioration of age-dependent impairment of membrane-bound ATPases and alterations in the redox biomarker level.
No takes yet. Share an insight, caveat, or question.
Arya et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: